US › Healthcare

InterCure Ltd. (INCR)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$0.96+1.05%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$70.1M

Revenue YoY

+23.9%

Net profit

$-17.0M

Profit YoY

+50.9%

EPS

$0.00

EPS estimate

$0.05

Net margin

-24.3%

EPS came in at 0.00 against a street estimate of 0.05 — a miss of 100.0%.

Key statistics

Market cap

$56.4M

Forward P/E

6.2

P/B

0.44

Book value

$7.59

EPS (TTM)

$-0.21

52-week high

$1.77

52-week low

$0.68

50-day MA

$0.98

200-day MA

$1.02

Beta

0.57

Analyst view

with an average price target of $33.56.

Shareholding

Insiders

39.17%

Institutions

1.11%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for InterCure Ltd. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.